The privately-owned NovImmune SA has appointed Penelope Ward as chief medical officer. Ms Ward previously worked at F. Hoffmann-La Roche AG where she was global head of rheumatology and local head of clinical development in the group’s global development center in the UK.
Based in Geneva, Switzerland, NovImmune is developing fully human monoclonal antibodies for immune-related disorders.
Copyright 2009 Evernow Publishing Ltd